MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Search

CorMedix Inc

Cerrado

SectorSanidad

7.62 1.2

Resumen

Variación precio

24h

Actual

Mínimo

7.58

Máximo

7.78

Métricas clave

By Trading Economics

Ingresos

89M

109M

Ventas

65M

104M

P/B

Media del Sector

5.516

87.826

Margen de beneficios

104.112

Empleados

64

EBITDA

37M

57M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+126.36% upside

Dividendos

By Dow Jones

Próximas Ganancias

24 mar 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

92M

960M

Apertura anterior

6.42

Cierre anterior

7.62

Noticias sobre sentimiento de mercado

By Acuity

46%

54%

146 / 370 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

CorMedix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 ene 2026, 00:16 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Drops Merger With JenaValve

10 ene 2026, 12:00 UTC

Adquisiciones, fusiones, absorciones

Copper Is the Prize in Mining Megadeals -- WSJ

10 ene 2026, 09:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

10 ene 2026, 09:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

10 ene 2026, 09:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

10 ene 2026, 09:00 UTC

Ganancias

Big Banks Expected to Post Higher Profits as Shares Surge -- Barrons.com

9 ene 2026, 22:18 UTC

Charlas de Mercado

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9 ene 2026, 21:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

9 ene 2026, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

9 ene 2026, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 ene 2026, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

9 ene 2026, 21:43 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9 ene 2026, 20:39 UTC

Charlas de Mercado

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9 ene 2026, 20:38 UTC

Charlas de Mercado

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9 ene 2026, 20:36 UTC

Adquisiciones, fusiones, absorciones

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9 ene 2026, 20:30 UTC

Charlas de Mercado

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9 ene 2026, 20:15 UTC

Charlas de Mercado

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9 ene 2026, 20:07 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

9 ene 2026, 20:07 UTC

Charlas de Mercado

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9 ene 2026, 19:58 UTC

Adquisiciones, fusiones, absorciones

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9 ene 2026, 19:42 UTC

Charlas de Mercado

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9 ene 2026, 19:38 UTC

Adquisiciones, fusiones, absorciones

Wolters Kluwer Acquires StandardFusion >WTKWY

9 ene 2026, 19:31 UTC

Ganancias

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9 ene 2026, 19:28 UTC

Ganancias

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9 ene 2026, 18:30 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9 ene 2026, 18:23 UTC

Charlas de Mercado

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9 ene 2026, 17:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

9 ene 2026, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 ene 2026, 17:19 UTC

Charlas de Mercado

Energy Prices Not Seen Supporting More Drilling -- Market Talk

9 ene 2026, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

Comparación entre iguales

Cambio de precio

CorMedix Inc previsión

Precio Objetivo

By TipRanks

126.36% repunte

Estimación a 12 Meses

Media 17 USD  126.36%

Máximo 22 USD

Mínimo 14 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

146 / 370 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
help-icon Live chat